Showing results (21-30 of 154) with videos related to
Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|August 11, 2020
Clinical Data Combined With Modeling and Simulation Indicate Unchanged Drug-Drug Interaction Magnitudes in the ElderlyFelix Stader, Perrine Courlet, Hannah Kinvig, et al.Clinical Pharmacokinetics|April 14, 2020
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIVPerrine Courlet, Laurent A Decosterd, Susana Alves Saldanha, et al.AIDS (London, England)|September 7, 2019
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIVPerrine Courlet, Felix Stader, Monia Guidi, et al.Journal of the International AIDS Society|February 4, 2020
The challenge of HIV treatment in an era of polypharmacyDavid Back, Catia MarzoliniExpert Review of Clinical Pharmacology|June 4, 2019
Prescribing issues in elderly individuals living with HIVCatia Marzolini, Françoise LivioClinical Pharmacokinetics|October 30, 2020
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIVPerrine Courlet, Monia Guidi, Susana Alves Saldanha, et al.Antiviral Therapy|August 23, 2012
Maternal antiretroviral prophylaxis and breastfeedingCatia Marzolini, Glenda E GrayPharmaceutics|April 23, 2022
Magnitude of Drug-Drug Interactions in Special PopulationsSara Bettonte, Mattia Berton, Catia MarzoliniThe Journal of Antimicrobial Chemotherapy|December 6, 2020
Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequityFrançoise Livio, Elisabeth Deutschmann, Giusi Moffa, et al.The Journal of Antimicrobial Chemotherapy|March 7, 2016
Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medicationsCatia Marzolini, Sara Gibbons, Saye Khoo, et al.Pageof 16